329 related articles for article (PubMed ID: 24585572)
21. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.
Bishop JA; Antonescu CR; Westra WH
Am J Surg Pathol; 2014 Sep; 38(9):1282-9. PubMed ID: 25007146
[TBL] [Abstract][Full Text] [Related]
22. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
23. Intra-articular epithelioid sarcoma showing mixed classic and proximal-type features: report of 2 cases, with immunohistochemical and molecular cytogenetic INI-1 study.
Kosemehmetoglu K; Kaygusuz G; Bahrami A; Raimondi SC; Kilicarslan K; Yildiz Y; Folpe AL
Am J Surg Pathol; 2011 Jun; 35(6):891-7. PubMed ID: 21566521
[TBL] [Abstract][Full Text] [Related]
24. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
Rekhi B; Vogel U
APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
[TBL] [Abstract][Full Text] [Related]
25. FNA of epithelioid sarcoma: Curie Institute experience and critical review of the literature.
Gajdzis P; Laé M; Klijanienko J
Cancer Cytopathol; 2018 Nov; 126(11):934-941. PubMed ID: 30291790
[TBL] [Abstract][Full Text] [Related]
26. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
27. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
[TBL] [Abstract][Full Text] [Related]
28. SWI/SNF-deficient thoraco-pulmonary neoplasms.
Sesboue C; Le Loarer F
Semin Diagn Pathol; 2021 May; 38(3):183-194. PubMed ID: 33451916
[TBL] [Abstract][Full Text] [Related]
29. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.
Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ
Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621
[No Abstract] [Full Text] [Related]
30. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
[TBL] [Abstract][Full Text] [Related]
31. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A
Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.
Kim KH; Roberts CW
Cancer Genet; 2014 Sep; 207(9):365-72. PubMed ID: 24853101
[TBL] [Abstract][Full Text] [Related]
33. SMARCB1/INI1 genetic inactivation is responsible for tumorigenic properties of epithelioid sarcoma cell line VAESBJ.
Brenca M; Rossi S; Lorenzetto E; Piccinin E; Piccinin S; Rossi FM; Giuliano A; Dei Tos AP; Maestro R; Modena P
Mol Cancer Ther; 2013 Jun; 12(6):1060-72. PubMed ID: 23576573
[TBL] [Abstract][Full Text] [Related]
34. Beyond SMARCB1 Loss: Recent Insights into the Pathobiology of Epithelioid Sarcoma.
Del Savio E; Maestro R
Cells; 2022 Aug; 11(17):. PubMed ID: 36078034
[TBL] [Abstract][Full Text] [Related]
35. INI1-deficient tumors: diagnostic features and molecular genetics.
Hollmann TJ; Hornick JL
Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399
[TBL] [Abstract][Full Text] [Related]
36. SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.
Bahrami A; Lee S; Caradine KD; Raimondi SC; Folpe AL
Cancer Genet; 2014 Sep; 207(9):437-40. PubMed ID: 25312828
[TBL] [Abstract][Full Text] [Related]
37. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
[TBL] [Abstract][Full Text] [Related]
38. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M
Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682
[TBL] [Abstract][Full Text] [Related]
39. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
[TBL] [Abstract][Full Text] [Related]
40. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas.
Kreiger PA; Judkins AR; Russo PA; Biegel JA; Lestini BJ; Assanasen C; Pawel BR
Mod Pathol; 2009 Jan; 22(1):142-50. PubMed ID: 18997735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]